OverviewSuggest Edit

Alector is a clinical-stage biopharmaceutical company that develops therapies for the treatment of neurodegenerative diseases. It offers AL001, a regulator of immune activity in the brain with genetic links to multiple neurodegenerative disorders, including frontotemporal dementia (FTD), Alzheimer’s disease, and Parkinson’s disease.

TypePublic
Founded2013
HQSouth San Francisco, CA, US
Websitealector.com
Employee Ratings4.3

Latest Updates

Employees (est.) (Mar 2020)126(+5%)
Job Openings26
Revenue (FY, 2020)$21.1 M
Share Price (Dec 2021)$20.6(-1%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Alector

Arnon Rosenthal

Arnon Rosenthal

Chief Executive Officer, Co-Founder and Director
Robert King

Robert King

Chief Development Officer
Sabah Oney

Sabah Oney

Chief Business Officer
Daniel Maslyar

Daniel Maslyar

Vice President, Clinical Development, Oncology
Kristina Vlaovic

Kristina Vlaovic

Vice President Regulatory and Pharmacovigilance
Virginia DeJesus-Ruef

Virginia DeJesus-Ruef

Vice President, Portfolio and Program Management
Show more

Alector Office Locations

Alector has offices in South San Francisco and Milpitas
South San Francisco, CA, US (HQ)
131 Oyster Point Blvd #600
Milpitas, CA, US
521 Cottonwood Dr #112
Show all (2)

Alector Financials and Metrics

Alector Revenue

Alector's revenue was reported to be $21.1 m in FY, 2020
USD

Revenue (FY, 2020)

21.1m

Net income (FY, 2020)

(190.2m)

EBIT (FY, 2020)

(195.2m)

Market capitalization (31-Dec-2021)

1.7b

Closing stock price (31-Dec-2021)

20.7

Cash (31-Dec-2020)

50.0m

EV

1.7b
Alector's current market capitalization is $1.7 b.
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

3.7m27.7m21.2m21.1m

Revenue growth, %

798%641%(23%)

General and administrative expense

6.5m11.9m35.1m59.4m

R&D expense

29.9m73.0m100.5m156.9m
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

4.8m7.1m2.7m5.6m6.9m2.7m7.2m3.2m

General and administrative expense

2.4m2.5m8.3m5.8m8.4m8.3m14.6m15.7m

R&D expense

11.7m16.8m28.5m20.6m25.6m28.5m34.6m34.1m

Operating expense total

14.1m19.3m36.8m26.4m34.1m36.8m49.2m49.8m
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

32.5m65.5m89.6m50.0m

Accounts Receivable

238.0k

Prepaid Expenses

285.0k2.8m4.4m8.2m

Current Assets

233.0m293.2m357.4m421.5m
Quarterly
USDQ3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

41.9m61.0m69.2m87.0m160.9m92.5m

Prepaid Expenses

3.9m5.5m3.7m4.0m7.7m6.4m

Current Assets

312.6m442.1m414.6m385.5m556.2m510.1m

PP&E

3.6m21.7m32.0m33.9m32.7m31.5m
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(32.5m)(52.2m)(105.4m)(190.2m)

Depreciation and Amortization

680.0k1.0m3.8m5.9m

Accounts Payable

(41.0k)(809.0k)152.0k2.4m

Cash From Operating Activities

(17.8m)127.5m(99.3m)(166.7m)
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(8.4m)(19.6m)(34.9m)(18.6m)(43.1m)(74.9m)(40.0m)(85.3m)

Depreciation and Amortization

212.0k464.0k743.0k298.0k1.1m2.4m1.4m2.9m

Accounts Payable

(783.0k)(830.0k)(604.0k)683.0k414.0k132.0k3.1m4.4m

Cash From Operating Activities

184.5m167.5m145.1m(23.6m)(41.6m)(70.5m)(32.3m)(78.3m)
USDFY, 2017

Financial Leverage

-4.5 x
Show all financial metrics

Alector Operating Metrics

FY, 2018FY, 2019

Immune System Targets Identified to Date

120

Patent Applications

100190

Patent Families

2530

Product Candidates

4
Show all operating metrics

Alector Acquisitions / Subsidiaries

Company NameDateDeal Size
Alector LLC

Alector Revenue Breakdown

Embed Graph

Alector revenue breakdown by business segment: 100.0% from Collaboration

Alector Cybersecurity Score

Cybersecurity ratingPremium dataset

B

82/100

SecurityScorecard logo

Alector Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Alector Online and Social Media Presence

Embed Graph

Alector News and Updates

Alector Announces Appointment of Sara Kenkare-Mitra, Ph.D., as President and Head of Research and Development

SOUTH SAN FRANCISCO, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced the appointment of Sara Kenkare-Mitra, Ph.D., as President and Head of Research and Development. In this newly created ro…

Alector Presents Preclinical Data from AL009 Multi-Siglec Inhibitor Program at the Society for Immunotherapy of Cancer’s 36th Annual Meeting

Preclinical Oncology Program Highlights Alector’s Expertise in Harnessing Components of the Innate Immune System to Impact Disease

Alector Presents New Data from Multiple Pipeline Programs at 2021 CTAD Conference

SOUTH SAN FRANCISCO, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, shared data from its AL003 and AL101 programs in poster presentations at the 14th Clinical Trials on Alzheimer's Disease (CTAD) conferenc…

Alector to Present New Data from Multiple Pipeline Programs at 2021 CTAD Conference and SITC Annual Meeting

Company to Host Analyst and Investor Conference Call on November 12 at 4:00 p.m. ET

Alector Announces Appointment of Elizabeth A. Garofalo, M.D., to its Board of Directors

SOUTH SAN FRANCISCO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced the addition of Elizabeth (Betsy) A. Garofalo, M.D., to the Company’s Board of Directors. Dr. Garofalo is a veteran biop…
Show more

Alector Frequently Asked Questions

  • When was Alector founded?

    Alector was founded in 2013.

  • Who are Alector key executives?

    Alector's key executives are Arnon Rosenthal, Robert King and Sabah Oney.

  • How many employees does Alector have?

    Alector has 126 employees.

  • What is Alector revenue?

    Latest Alector annual revenue is $21.1 m.

  • What is Alector revenue per employee?

    Latest Alector revenue per employee is $167.4 k.

  • Who are Alector competitors?

    Competitors of Alector include ACADIA Pharmaceuticals, Cortexyme and Verge Genomics.

  • Where is Alector headquarters?

    Alector headquarters is located at 131 Oyster Point Blvd #600, South San Francisco.

  • Where are Alector offices?

    Alector has offices in South San Francisco and Milpitas.

  • How many offices does Alector have?

    Alector has 2 offices.